SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001654954-21-004509
Filing Date
2021-04-22
Accepted
2021-04-22 06:02:39
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM gtbp_posam.htm POS AM 493736
2 CONSENT OF SELIGSON & GIANNATTASIO, LLP gtbp_ex231.htm EX-23.1 4691
3 CONSENT OF WEINBERG & COMPANY gtbp_ex23-2.htm EX-23.2 4352
4 IMAGE gtbp_posam000.jpg GRAPHIC 1675
  Complete submission text file 0001654954-21-004509.txt   506525
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-251311 | Film No.: 21843139
SIC: 2834 Pharmaceutical Preparations